Cargando…

Prognostic role of CD74, CD10 and Ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: a retrospective study

BACKGROUND: Diagnosis and treatment of diffuse malignant peritoneal mesothelioma (DMPM) are still challenging. The aim of the present study was to explore the correlation between CD74, CD10, Ki-67 and clinicopathological parameters, and identify independent prognostic factors of DMPM. METHODS: Seven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Yufei, Li, Chunying, Liu, Yingying, Tian, Liang, Yang, Dongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161649/ https://www.ncbi.nlm.nih.gov/pubmed/37147569 http://dx.doi.org/10.1186/s12885-023-10871-w

Ejemplares similares

Osteopontin, GLUT1 and Ki‐67 expression in malignant peritoneal mesothelioma: prognostic implications
por: Liu, Yingying, et al.
Publicado: (2021)

Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma
por: Liang, Yufei, et al.
Publicado: (2019)

Malignant Pleural Mesothelioma—Does Ki67 Make the Grade?
por: Prall, Owen W.J.
Publicado: (2021)

Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade
por: Shubham, Swasti, et al.
Publicado: (2019)

Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis
por: Ramezani, Mazaher, et al.
Publicado: (2019)

Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas
por: Herstad, Kristin M. V., et al.
Publicado: (2021)

CD74: a new prognostic factor for patients with malignant pleural mesothelioma
por: Otterstrom, C, et al.
Publicado: (2014)

Immunohistochemical detection of Hsp90 and Ki-67 in pterygium
por: Sebastiá, Roberto, et al.
Publicado: (2013)

An Immunohistochemical Study Showing Ki-67 as an Analytical Marker in Oral Malignant and Premalignant Lesions
por: Dash, Kailash C, et al.
Publicado: (2020)

Immunohistochemical expression of p53, Ki67, α-SMA, CD44 and CD31 in different histological subtypes of basal cell carcinoma
por: Cojocaru, Anca, et al.
Publicado: (2022)

Analysis of prognostic factors of patients with malignant peritoneal mesothelioma
por: Yin, Wenjie, et al.
Publicado: (2018)

Diffuse malignant peritoneal mesothelioma: A review
por: Sun, Luanbiao, et al.
Publicado: (2023)

Ki-67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively
por: CAMPOS, MARCELO, et al.
Publicado: (2013)

Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study
por: Pezzuto, Federica, et al.
Publicado: (2020)

Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma
por: Zhang, Guozun, et al.
Publicado: (2020)

Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma
por: D'Amato-Brito, Cintia, et al.
Publicado: (2016)

IMMUNOHISTOCHEMICAL ANALYSIS BY KI67 AND IDH1 IN PATIENTS WITH CHONDROSARCOMA
por: RIBEIRO, MARCELO BARBOSA, et al.
Publicado: (2023)

Diffuse malignant peritoneal mesothelioma mimicking ovarian cancer.
por: Houssaini, Zaynab Iraqi, et al.
Publicado: (2021)

Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma
por: Kusamura, Shigeki, et al.
Publicado: (2023)

EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence
por: Abdel-Aziz, Azza, et al.
Publicado: (2012)

Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma
por: Indirapriyadarsini, K, et al.
Publicado: (2018)

Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas
por: Aman, Nguiessan Alphonse, et al.
Publicado: (2019)

Maspin, Syndecan-1, and Ki-67 in the Odontogenic Keratocyst: An Immunohistochemical Analysis
por: Hammad, Huda M., et al.
Publicado: (2020)

Turnover of CD4(+) and CD8(+) T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen
por: Sachsenberg, Nicolas, et al.
Publicado: (1998)

Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion
por: Xie, Xuehua, et al.
Publicado: (2022)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Diffuse malignant peritoneal mesothelioma presenting as small bowel obstruction
por: Tagliaferri, Ariana R., et al.
Publicado: (2023)

A New CD10 Antibody Inhibits the Growth of Malignant Mesothelioma
por: Mizutani, Natsuko, et al.
Publicado: (2021)

CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis
por: LU, CANRONG, et al.
Publicado: (2013)

Ki‐67/CD3 ratio in the diagnosis of chronic inflammatory enteropathy in dogs
por: Karlovits, Sonja, et al.
Publicado: (2019)

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
por: Ghanim, B, et al.
Publicado: (2015)

Immunohistochemical analysis of Ki-67 in dental follicle of asymptomatic impacted third molars
por: Kucukkolbasi, Hasan, et al.
Publicado: (2014)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Dimensional Analysis of CD44(High) CD24(Low) and Ki67 in Triple Negative Breast Cancer
por: Tan, Betty, et al.
Publicado: (2019)

Immunohistochemical expression of COX-2, Ki-67, Bcl-2, Bax, VEGF and CD105 according to histological grading in oral squamous cell carcinoma
por: Escobar, Enrico, et al.
Publicado: (2023)

Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma
por: Napolitano, Andrea
Publicado: (2019)

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma
por: Belfiore, Antonino, et al.
Publicado: (2019)

Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases
por: Gros, Louis, et al.
Publicado: (2021)

Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r9n9iqo731564pon6gpbu29rsf